Located at Chestnut Run Innovation & Science Park, the Merck Wilmington Biotech project will comprise laboratory, ...

Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.

More than 80% of oncologists participating in a global survey consider insurance a major barrier to timely cancer care.

Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what ...

German stocks are up firmly in positive territory on Friday amid easing trade tensions after China said it has kept the doors open for discussions with the United States. At ...

QPS Holdings is expanding with support from a $1.1 million lab space grant and a $162,000 jobs performance grant from the ...

Released every Friday, our quiz covers a wide range of topics. Think you can ace this week's quiz? Test your local news IQ ...

Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than ...

Gov. Matt Meyer plans to repeal Delaware's electric vehicle mandate if the federal government doesn’t beat him to it.

This valuable study provides insights into a key question in comparative neuroanatomy and development. The authors provide evidence of the role for a particular micro-RNA in regulating the development ...

There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient pool and evolving healthcare infrastructure. However, ...